Testing effectiveness (Phase 2)Looking for participantsNCT06033703
What this trial is testing
Topical Netarsudil for the Prevention of Proliferative Vitreoretinopathy in Patients With Retinal Detachment
Who this might be right for
Rhegmatogenous Retinal DetachmentProliferative Vitreoretinopathy
Massachusetts Eye and Ear Infirmary 48